Stable Angina – A Complete Patient Guide
Overview
Stable angina (also called stable ischemic chest pain) is a predictable pattern of chest discomfort that occurs when the heart muscle temporarily receives less oxygen‑rich blood than it needs, usually during physical exertion or emotional stress. The underlying problem is atherosclerotic narrowing of the coronary arteries, but unlike the more dangerous unstable angina or heart attack, the blockage is typically not complete and symptoms are reproducible.
Stable angina most often affects adults > 45 years of age, and the prevalence rises sharply with age. According to the American Heart Association, about 9 million adults in the United States experience stable angina each year, representing roughly 3 % of the adult population. Worldwide, the WHO estimates that coronary artery disease (CAD)—the umbrella condition that includes stable angina—affects over 126 million people and is the leading cause of death globally.1
Symptoms
Symptoms are usually “typical” but can vary. They often appear predictably with certain triggers and subside with rest or nitroglycerin.
Typical Chest Pain
- Location: Substernal (behind the breastbone), may radiate to left arm, neck, jaw, or back.
- Quality: Described as pressure, tightness, squeezing, or heaviness.
- Duration: Usually lasts < 5 minutes; most episodes end within 2–3 minutes after rest or medication.
Associated Symptoms
- Shortness of breath (dyspnea) during activity.
- Cold sweats.
- Nausea or indigestion‑like feeling.
- Fatigue, especially after exertion.
- Light‑headedness or dizziness.
Atypical Presentations
Up to 30 % of women, older adults, and diabetic patients may experience “silent” or atypical angina, presenting mainly with dyspnea, fatigue, or epigastric discomfort rather than classic chest pressure.2
Causes and Risk Factors
Stable angina is caused by a chronic, fixed narrowing of one or more coronary arteries due to atherosclerotic plaque. The reduced lumen limits blood flow when the heart’s demand rises.
Primary Causes
- **Atherosclerosis** – buildup of cholesterol‑rich plaque in the coronary arteries.
- **Coronary artery spasm** (less common) – transient constriction of a coronary artery.
Major Risk Factors
- Age ≥ 45 years (men) or ≥ 55 years (women).
- Male sex (women catch up after menopause).
- Family history of premature CAD (first‑degree relative < 55 yr for men, < 65 yr for women).
- Tobacco use – current smokers have a 2–4‑fold higher risk.
- Hypertension – BP ≥ 140/90 mm Hg or on antihypertensive therapy.
- Hyperlipidemia – LDL‑cholesterol ≥ 130 mg/dL or triglycerides ≥ 150 mg/dL.
- Diabetes mellitus – especially with poorly controlled glucose (HbA1c ≥ 7 %).
- Obesity (BMI ≥ 30 kg/m²) and sedentary lifestyle.
- Chronic kidney disease, metabolic syndrome, and inflammatory conditions (e.g., rheumatoid arthritis).
For many patients, several risk factors cluster together, accelerating plaque formation.
Diagnosis
Diagnosing stable angina is a stepwise process that combines clinical assessment, non‑invasive testing, and, when needed, invasive coronary evaluation.
1. Clinical History & Physical Exam
- Characterize the chest pain (onset, location, triggers, relief).
- Assess risk‑factor profile.
- Listen for murmurs, gallops, or signs of heart failure.
2. Resting Electrocardiogram (ECG)
May be normal in stable angina but can show prior infarction, left‑ventricular hypertrophy, or baseline ST‑segment changes.
3. Exercise Stress Test (EST) with ECG
Standard treadmill or bike test assesses exercise‑induced ischemia. A positive test shows ≥ 1 mm horizontal or down‑sloping ST‑segment depression 0.08 s after the J point.
4. Pharmacologic Stress Imaging (if unable to exercise)
- Dobutamine stress echocardiography.
- Vasodilator (adenosine, regadenoson) nuclear perfusion imaging (SPECT or PET).
- Stress cardiac MRI.
5. Coronary Computed Tomography Angiography (CCTA)
Non‑invasive visualization of coronary plaque and stenosis; useful in low‑ to intermediate‑risk patients.
6. Invasive Coronary Angiography
Gold standard when non‑invasive tests are equivocal or when revascularization is being considered.
7. Laboratory Tests
- Lipid panel, fasting glucose, HbA1c.
- High‑sensitivity C‑reactive protein (hs‑CRP) for inflammation (optional).
Treatment Options
Therapy aims to relieve symptoms, improve quality of life, and prevent progression to myocardial infarction (MI) or death.
1. Medications
- Nitrates (short‑acting sublingual nitroglycerin for acute relief; long‑acting isosorbide dinitrate for prophylaxis).
- Beta‑blockers (first‑line for symptom control; reduce myocardial oxygen demand). Examples: metoprolol, atenolol.
- Calcium‑channel blockers (dihydropyridine – amlodipine; non‑dihydropyridine – diltiazem) – useful when beta‑blockers are contraindicated.
- Antiplatelet therapy – low‑dose aspirin (81 mg daily) reduces clot formation; clopidogrel may be added post‑PCI.
- Statins – high‑intensity atorvastatin or rosuvastatin to lower LDL‑C < 70 mg/dL (or < 55 mg/dL in very high risk).
- ACE inhibitors/ARBs – indicated for hypertension, diabetes, or left‑ventricular dysfunction.
- Ranolazine – an option for persistent angina despite beta‑blocker and nitrate therapy.
2. Revascularization Procedures
- Percutaneous coronary intervention (PCI) – balloon angioplasty with stent placement to open the narrowed artery.
- Coronary artery bypass grafting (CABG) – surgical bypass for multi‑vessel disease or left‑main involvement.
Guidelines from the ACC/AHA recommend PCI or CABG when angina is refractory to optimal medical therapy, when there is significant left‑main disease, or when large areas of myocardium are at risk.3
3. Lifestyle Modifications
- Smoking cessation (nicotine replacement, counseling, or prescription meds).
- Adopt a Mediterranean‑style diet rich in fruits, vegetables, whole grains, nuts, and oily fish.
- Physical activity – at least 150 minutes/week of moderate aerobic exercise (e.g., brisk walking).
- Weight loss to achieve BMI < 25 kg/m².
- Limit alcohol (≤ 1 drink/day for women, ≤ 2 drinks/day for men).
- Stress management – mindfulness, yoga, or cardiac rehab programs.
Living with Stable Angina
Managing stable angina is a daily partnership between you and your healthcare team.
Daily Monitoring
- Keep a symptom diary – record time, activity, pain intensity (0‑10 scale), and response to medication.
- Check blood pressure and heart rate at least weekly.
- Take all prescribed medicines exactly as directed; use a pill organizer if helpful.
Exercise Guidelines
- Start with low‑intensity activity (e.g., 5‑minute warm‑up walk).
- Gradually increase to 30‑45 minutes of moderate activity 5 days/week.
- Stop and rest if chest discomfort or undue shortness of breath occurs; use nitroglycerin if prescribed and seek care if pain persists > 5 min.
Nutrition Tips
- Swap saturated fats (butter, fatty red meat) for unsaturated fats (olive oil, avocado, nuts).
- Increase soluble fiber (oats, beans, apples) to lower LDL‑C.
- Choose low‑sodium options; aim < 2,300 mg/day.
Stress & Emotional Health
Stress can trigger angina episodes. Consider cardiac rehabilitation, counseling, or support groups. Regular sleep (7‑9 hours) also stabilizes blood pressure and heart rhythm.
Medication Safety
- Store nitrates away from heat and direct sunlight.
- Do not combine nitrates with phosphodiesterase‑5 inhibitors (e.g., sildenafil) – risk of severe hypotension.
- Report side‑effects (e.g., bradycardia, dizziness) promptly.
Prevention
Because stable angina reflects underlying atherosclerosis, primary prevention targets the same risk factors.
- Control blood pressure – goal < 130/80 mm Hg (ACC/AHA 2017 guideline).
- Maintain LDL‑C < 70 mg/dL for very high‑risk patients; < 100 mg/dL for most others.
- Achieve glycemic control – target HbA1c < 7 % (individualized).
- Quit smoking – use quitlines, counseling, and nicotine replacement.
- Stay active – incorporate movement into daily routine (stairs, walking meetings).
- Regular screening – lipid panel every 4‑6 years for adults ≥ 20 yr, earlier if risk factors present.
Complications
If left untreated or inadequately managed, stable angina can progress to more serious conditions:
- Acute coronary syndrome (ACS) – unstable angina or myocardial infarction due to plaque rupture or thrombosis.
- Heart failure – chronic ischemia weakens the myocardium.
- Arrhythmias – especially ventricular tachycardia in the setting of scar tissue.
- Sudden cardiac death – rare in stable angina alone but possible if coronary disease becomes severe.
- Reduced functional capacity – leading to decreased independence and quality of life.
When to Seek Emergency Care
- Chest pain or discomfort that is new, worsening, or lasts longer than 5 minutes despite rest or nitroglycerin.
- Pain radiating to the left arm, jaw, back, or stomach accompanied by sweating, nausea, or shortness of breath.
- Sudden weakness, numbness, or difficulty speaking (possible stroke).
- Fainting or near‑fainting episodes.
- Rapid or irregular heartbeat (palpitations) together with chest discomfort.
These signs may indicate a heart attack or unstable angina, which require immediate treatment.
Sources:
1. World Health Organization. Cardiovascular diseases (CVD) Fact Sheet. 2023.
2. Bairey Merz CN, et al. Sex Differences in Ischemic Heart Disease. J Am Coll Cardiol. 2022.
3. 2021 ACC/AHA Guideline for the Management of Patients With Stable Ischemic Heart Disease. Circulation. 2021.
4. Mayo Clinic. Stable angina. Updated 2024.
5. CDC. Heart Disease Facts. 2023.